Mark Devlin
Corporate Officer/Principal en AMPLIA THERAPEUTICS LIMITED .
Perfil
Mark Devlin is currently working as a Scientific Adviser at Amplia Therapeutics Ltd.
Previously, he held positions as the Chief Executive Officer at CTxONE, the Chief Operating Officer at Cancer Therapeutics CRC Pty Ltd., and an Associate Professor at Peter MacCallum Cancer Institute.
Dr. Devlin has an MBA from Melbourne Business School and a doctorate from the University of Melbourne.
Cargos activos de Mark Devlin
| Empresas | Cargo | Inicio |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Mark Devlin.
| Empresas | Cargo | Fin |
|---|---|---|
Cancer Therapeutics CRC Pty Ltd.
 Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Chief Operating Officer | 01/09/2019 |
Peter MacCallum Cancer Institute
 Peter MacCallum Cancer Institute General GovernmentGovernment Peter MacCallum Cancer Institute is a world-renowned cancer research, education, and treatment center. The non-profit company is based in Melbourne, Australia. The institute is dedicated to providing care for individuals affected by cancer. | Corporate Officer/Principal | 01/09/2019 |
| CTxONE | Chief Executive Officer | - |
Formación de Mark Devlin.
| Melbourne Business School | Masters Business Admin |
| University of Melbourne | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AMPLIA THERAPEUTICS LIMITED | Health Technology |
| Empresas privadas | 3 |
|---|---|
Cancer Therapeutics CRC Pty Ltd.
Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Peter MacCallum Cancer Institute is a world-renowned cancer research, education, and treatment center. The non-profit company is based in Melbourne, Australia. The institute is dedicated to providing care for individuals affected by cancer. | Government |
| CTxONE |
- Bolsa de valores
- Insiders
- Mark Devlin
